Literature DB >> 27619066

Maternal cardiac function at 35-37 weeks' gestation: prediction of pre-eclampsia and gestational hypertension.

G P Guy1, H Z Ling1, P Garcia1, L C Poon1,2, K H Nicolaides1.   

Abstract

OBJECTIVE: To investigate the potential value of combining maternal factors with multiples of the normal median values of maternal cardiovascular parameters at 35-37 weeks' gestation in the prediction of pre-eclampsia (PE) and gestational hypertension (GH).
METHODS: In 2764 singleton pregnancies maternal characteristics and medical history were recorded; uterine artery pulsatility index (UtA-PI), mean arterial pressure (MAP) and maternal cardiovascular parameters were measured. Multivariable logistic regression analysis was then used to determine if the maternal factors and maternal cardiovascular parameters made a significant contribution to predicting PE and GH. The performance of screening was determined by the area under receiver-operating characteristics curves.
RESULTS: In pregnancies that subsequently delivered with PE or GH, total peripheral resistance and MAP were higher and maternal cardiac output was lower, mainly owing to a decrease in heart rate in PE and a decrease in stroke volume in GH. The increases in total peripheral resistance and MAP were inversely related to gestational age at delivery. The performance of screening for PE and GH achieved by maternal characteristics and medical history was improved by the inclusion of MAP, but not by UtA-PI or maternal cardiovascular parameters.
CONCLUSIONS: In women developing term PE total peripheral resistance and MAP are increased and maternal cardiac output is reduced. However, assessment of maternal cardiac function at 35-37 weeks' gestation is unlikely to improve the performance of screening for PE provided by maternal factors and MAP alone.
Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cardiac output; gestational hypertension; maternal cardiovascular function; pre-eclampsia; third-trimester screening; total peripheral resistance

Mesh:

Year:  2017        PMID: 27619066     DOI: 10.1002/uog.17300

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  5 in total

1.  Magnesium Sulfate Prevents Placental Ischemia-Induced Increases in Brain Water Content and Cerebrospinal Fluid Cytokines in Pregnant Rats.

Authors:  Linda W Zhang; Junie P Warrington
Journal:  Front Neurosci       Date:  2016-12-08       Impact factor: 4.677

2.  Agreement between preload reserve measured by impedance cardiography and echocardiography during pregnancy.

Authors:  Huan Liang; Åse Vårtun; Ganesh Acharya
Journal:  Arch Gynecol Obstet       Date:  2018-04-05       Impact factor: 2.344

3.  Efficacy and safety of combination of magnesium sulfate, phentolamine and nifedipine in treatment of patients with hypertensive disorder complicating pregnancy.

Authors:  Jinggui Zhang; Jun Li
Journal:  Exp Ther Med       Date:  2019-08-30       Impact factor: 2.447

4.  Artificial intelligence-assisted prediction of preeclampsia: Development and external validation of a nationwide health insurance dataset of the BPJS Kesehatan in Indonesia.

Authors:  Herdiantri Sufriyana; Yu-Wei Wu; Emily Chia-Yu Su
Journal:  EBioMedicine       Date:  2020-04-10       Impact factor: 8.143

Review 5.  Renal and cardiovascular repercussions in preeclampsia and their impact on fluid management: a literature review.

Authors:  Wallace Andrino da Silva; Aline Macedo Pinheiro; Paulo Henrique Lima; Luiz Marcelo S Malbouisson
Journal:  Braz J Anesthesiol       Date:  2021-04-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.